PJ
Therapeutic Areas
Catalyst Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AGAMREE (vamorolone) | Duchenne Muscular Dystrophy (DMD) | Marketed |
| FIRDAPSE (amifampridine) | Lambert-Eaton Myasthenic Syndrome (LEMS) | Marketed |
Leadership Team at Catalyst Pharmaceuticals
RD
Rich Daly
President and Chief Executive Officer
WA
Will Andrews, MD
Chief Medical Officer
AB
Angie Bechan
EVP, Chief Corporate Affairs Officer
TB
Tara Bey
VP, Quality
JD
Jeff Del Carmen
EVP and Chief Commercial Officer
BE
Brian Elsbernd
Chief Legal and Compliance Officer
PF
Paul Friel
EVP, Corporate Operations
MK
Mike Kalb
EVP and Chief Financial Officer
SM
Steve Miller, PhD
EVP, Chief Operations Officer, and Chief Scientific Officer
GR
Gregg Russo
Chief Human Resources Officer